JG

John Gong

Chairman and CEO

思路迪医药

Shanghai, Shanghai


Contact Information

Email
Unlock
LinkedIn

Company Information

Company
思路迪医药
Industry
pharmaceuticals
Employees
76.0
Seniority
C suite

Technologies

Mobile Friendly Baidu Ads OpenSSL Apache Remote

Keywords

pharmaceutical manufacturing cancer treatment prolonged survival quality of life chronic disease management pd-l1 immunotherapy biopharmaceuticals precision medicine mrna therapies therapeutic pipelines clinical trials envafolimab combination therapy regulatory approval fda r&d innovation immune response tumor markers biomarkers immune checkpoint inhibitors targeted therapies biologics fda ind therapeutic landscape oncology cancer biomarkers biotechnology cell therapy genetic therapy tumor microenvironment personalized treatment clinical research malignant tumors pharmaceutical development cancer immunology pharmacodynamics pharmacokinetics bioprocessing cd47 inhibitors fgfr targeting kras mutations sema4d tki therapies combination treatments mutant allele detection adaptive immunotherapy translational medicine disease progression tumor microenvironment modulation pharmaceuticals medical health care health wellness & fitness hospital & health care

Get Full Contact Details

Subscribe to reveal email addresses and export contacts.

View Plans